Skip to main navigation Skip to search Skip to main content

Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection

Research output: Contribution to journalArticlepeer-review

33 Scopus citations
Original languageEnglish
Pages (from-to)451-452
Number of pages2
JournalIsrael Medical Association Journal
Volume3
Issue number6
StatePublished - 1 Dec 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Dermal leishmaniasis
  • Highly active anti-retroviral therapy
  • Human immunodeficiency virus
  • Immune reconstitution
  • Kala-azar

ASJC Scopus subject areas

  • General Medicine

Cite this